[1] LI Z, LI Z, CHEN X, et al. Comparison between modified facet joint fusion and posterolateral fusion for the treatment of lumbar degenerative diseases: a retrospective study. BMC Surg. 2022;22(1):29.
[2] TOBERT DG, ANTOCI V, PATEL SP, et al. Adjacent Segment Disease in the Cervical and Lumbar Spine. Clin Spine Surg. 2017;30(3):94-101.
[3] ETULAIN J. Platelets in wound healing and regenerative medicine. Platelets. 2018; 29(6):556-568.
[4] CHENG J, SANTIAGO KA, NGUYEN JT, et al. Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma: follow-up at 5-9 years. Regen Med. 2019;14(9):831-840.
[5] EVERTS P A, VAN ERP A, DESIMONE A, et al. Platelet Rich Plasma in Orthopedic Surgical Medicine. Platelets. 2021;32(2):163-174.
[6] PADILLA S, SÁNCHEZ M, VAQUERIZO V, et al. Platelet-Rich Plasma Applications for Achilles Tendon Repair: A Bridge between Biology and Surgery. Int J Mol Sci. 2021;22(2):824.
[7] FEIGIN K, SHOPE B. Use of Platelet-Rich Plasma and Platelet-Rich Fibrin in Dentistry and Oral Surgery: Introduction and Review of the Literature. J Vet Dent. 2019;36(2):109-123.
[8] WANG Y, CHE M, XIN J, et al. The role of IL-1β and TNF-α in intervertebral disc degeneration. Biomed Pharmacother. 2020;131:110660.
[9] EVERTS P, ONISHI K, JAYARAM P, et al. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020; 21(7794):7794.
[10] RISBUD MV, SHAPIRO IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44-56.
[11] ZHANG Y, HE F, CHEN Z, et al. Melatonin modulates IL-1β-induced extracellular matrix remodeling in human nucleus pulposus cells and attenuates rat intervertebral disc degeneration and inflammation. Aging (Albany NY). 2019; 11(22):10499-10512.
[12] LIAN C, GAO B, WU Z, et al. Collagen type II is downregulated in the degenerative nucleus pulposus and contributes to the degeneration and apoptosis of human nucleus pulposus cells. Mol Med Rep. 2017;16(4):4730-4736.
[13] BECKETT MC, RALPHS JR, CATERSON B, et al. The transmembrane heparan sulphate proteoglycan syndecan-4 is involved in establishment of the lamellar structure of the annulus fibrosus of the intervertebral disc. Eur Cell Mater. 2015;30:69-88.
[14] KIRCHNER F, PINAR A, MILANI I, et al. Vertebral intraosseous plasma rich in growth factor (PRGF-Endoret) infiltrations as a novel strategy for the treatment of degenerative lesions of endplate in lumbar pathology: description of technique and case presentation. J Orthop Surg Res. 2020;15(1):72.
[15] GULLUNG G, WOODALL W, TUCCI M, et al. Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid Based Spine Care J. 2011;2(4):13-18.
[16] 卢正操, 蒋强, 付本升, 等. 经皮脊柱内镜联合富血小板血浆注射治疗青壮年腰椎间盘突出症[J]. 转化医学杂志,2021,10(1):30-34.
[17] XU J, XIE G, YANG W, et al. Platelet-rich plasma attenuates intervertebral disc degeneration via delivering miR-141-3p-containing exosomes. Cell Cycle. 2021; 20(15):1487-1499.
[18] 王乙. TGF-β通路在椎间盘退变分子生物学进程中作用机制的研究进展[J]. 吉林大学学报(医学版),2020,46(5):1105-1110.
[19] 李大鹏, 吴燕, 岳佳伟, 等. 胰岛素样生长因子1通过PI3K/Akt信号通路促进髓核细胞聚集蛋白聚糖及Ⅱ型胶原的表达[J]. 中国组织工程研究,2017, 21(8):1202-1208.
[20] SZÖŐR Á, UJLAKY-NAGY L, TÓTH G, et al. Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms. Cell Signal. 2016;28(2):81-93.
[21] ZHOU T, LI X, LI G, et al. Injectable and thermosensitive TGF-β1-loaded PCEC hydrogel system for in vivo cartilage repair. Sci Rep. 2017;7(1):10553.
[22] ZHANG J, LI Z, CHEN F, et al. TGF-β1 suppresses CCL3/4 expression through the ERK signaling pathway and inhibits intervertebral disc degeneration and inflammation-related pain in a rat model. Exp Mol Med. 2017;49(9):e379.
[23] SEGABINAZZI L, PODICO G, ROSSER MF, et al. Three Manual Noncommercial Methods to Prepare Equine Platelet-Rich Plasma. Animals (Basel). 2021;11(6):1478.
[24] GUPTA V, PARIHAR AS, PATHAK M, et al. Comparison of Platelet-Rich Plasma Prepared Using Two Methods: Manual Double Spin Method versus a Commercially Available Automated Device. Indian Dermatol Online J. 2020;11(4):575-579.
[25] WEIBRICH G, KLEIS WK. Curasan PRP kit vs. PCCS PRP system. Collection efficiency and platelet counts of two different methods for the preparation of platelet-rich plasma. Clin Oral Implants Res. 2002;13(4):437-443.
[26] 陈华, 刘浩. 生物活性因子治疗椎间盘退变性疾病的研究进展[J]. 华西医学, 2017,32(11):1782-1786.
[27] ZHU B, CUI G, ZHANG Q, et al. Desumoylation of aggrecan and collagen II facilitates degradation via aggrecanases in IL-1β-mediated osteoarthritis. J Pain Res. 2019;12:2145-2153.
[28] WANG SZ, FAN WM, JIA J, et al. Is exclusion of leukocytes from platelet-rich plasma (PRP) a better choice for early intervertebral disc regeneration? Stem Cell Res Ther. 2018;9(1):199.
[29] 王书军, 温从吉, 李诗言. 不同套装制备的富血小板血浆中细胞及细胞因子成分的比较[J]. 中华关节外科杂志(电子版),2016,10(6):592-597.
[30] DEGEN RM, BERNARD JA, OLIVER KS, et al. Commercial Separation Systems Designed for Preparation of Platelet-Rich Plasma Yield Differences in Cellular Composition. Hss J. 2017;13(1):75-80.
[31] DE MELO BAG, MARTINS SHIMOJO AA, MARCELINO PEREZ AG, et al. Distribution, recovery and concentration of platelets and leukocytes in L-PRP prepared by centrifugation. Colloids Surf B Biointerfaces. 2018;161:288-295.
|